Published in J Biol Chem on March 26, 2010
Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB. Nat Med (2011) 3.15
The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol (2014) 2.13
Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci (2011) 1.93
Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes (2014) 1.85
Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension (2011) 1.46
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res (2015) 1.45
Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension (2011) 1.30
The sympathetic nervous system alterations in human hypertension. Circ Res (2015) 1.28
Postmenopausal hypertension. Am J Hypertens (2011) 1.22
Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension (2012) 1.21
Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol (2013) 1.16
A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am J Physiol Heart Circ Physiol (2012) 1.14
Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats. J Appl Physiol (1985) (2012) 1.08
Sex and gender differences in control of blood pressure. Clin Sci (Lond) (2013) 1.08
Hypertension in postmenopausal women. Curr Hypertens Rep (2012) 1.07
Obesity-associated hypertension: recent progress in deciphering the pathogenesis. Hypertension (2014) 1.06
Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab (2013) 1.05
Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of age. Hypertension (2013) 1.02
Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen. J Physiol (2014) 1.01
Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice. Int J Obes (Lond) (2011) 1.00
Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res (2012) 1.00
Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. Am J Physiol Regul Integr Comp Physiol (2013) 0.96
Gender differences in developmental programming of cardiovascular diseases. Clin Sci (Lond) (2016) 0.93
Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Pivotal roles of monocytes/macrophages in stroke. Mediators Inflamm (2013) 0.92
Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications. Cell Metab (2014) 0.92
Influence of age on the association between lifestyle factors and risk of hypertension. J Am Soc Hypertens (2012) 0.92
Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase. Proc Natl Acad Sci U S A (2012) 0.91
Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells. PLoS One (2013) 0.91
Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation. J Physiol (2014) 0.91
Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension (2013) 0.91
Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life (2013) 0.90
Role of leptin and central nervous system melanocortins in obesity hypertension. Curr Opin Nephrol Hypertens (2013) 0.90
Adipose tissue and metabolic syndrome: too much, too little or neither. Eur J Clin Invest (2015) 0.89
Impaired blood pressure compensation following hemorrhage in conscious obese Zucker rats. Life Sci (2013) 0.89
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor. Hypertension (2011) 0.89
Facilitation of breathing by leptin effects in the central nervous system. J Physiol (2015) 0.89
Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. J Med Chem (2011) 0.89
Fetal programming and cardiovascular pathology. Compr Physiol (2015) 0.88
Obesity-induced increases in sympathetic nerve activity: sex matters. Auton Neurosci (2014) 0.87
Leptin acts in the forebrain to differentially influence baroreflex control of lumbar, renal, and splanchnic sympathetic nerve activity and heart rate. Hypertension (2013) 0.87
Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.87
Role of the Paraventricular Nucleus of the Hypothalamus in the Sympathoexcitatory Effects of Leptin. Hypertension (2015) 0.86
Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight. Pflugers Arch (2012) 0.86
Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters. BMC Genomics (2015) 0.86
Adipocyte dysfunction and hypertension. Am J Cardiovasc Dis (2012) 0.85
Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. Int J Obes (Lond) (2013) 0.85
The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda) (2014) 0.85
Sodium-retaining effect of insulin in diabetes. Am J Physiol Regul Integr Comp Physiol (2012) 0.85
Fetal cardiac autonomic control during breathing and non-breathing epochs: the effect of maternal exercise. Early Hum Dev (2012) 0.85
Vascular effects of deletion of melanocortin-4 receptors in rats. Physiol Rep (2013) 0.85
Biphasic effect of melanocortin agonists on metabolic rate and body temperature. Cell Metab (2014) 0.85
Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis. J Physiol (2016) 0.85
Leptin into the rostral ventral lateral medulla (RVLM) augments renal sympathetic nerve activity and blood pressure. Front Neurosci (2014) 0.85
Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish Obese Subjects (SOS) study. PLoS One (2012) 0.84
Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide. PLoS One (2014) 0.83
Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function. Acta Physiol (Oxf) (2014) 0.83
Control of respiratory and cardiovascular functions by leptin. Life Sci (2015) 0.83
PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin. Mol Metab (2013) 0.82
The nucleus of the solitary tract and the coordination of respiratory and sympathetic activities. Front Physiol (2014) 0.82
Role of lipotoxicity in endothelial dysfunction. Heart Fail Clin (2012) 0.82
Ectopic Adipose Tissue Storage in the Left and the Right Renal Sinus is Asymmetric and Associated With Serum Kidney Injury Molecule-1 and Fibroblast Growth Factor-21 Levels Increase. EBioMedicine (2016) 0.82
The mechanisms underlying fructose-induced hypertension: a review. J Hypertens (2015) 0.81
Zinc, copper, and blood pressure: Human population studies. Med Sci Monit (2013) 0.80
Leptin into the ventrolateral medulla facilitates chemorespiratory response in leptin-deficient (ob/ob) mice. Acta Physiol (Oxf) (2014) 0.80
New actions of an old friend: perivascular adipose tissue's adrenergic mechanisms. Br J Pharmacol (2016) 0.79
Visceral adiposity syndrome. Diabetol Metab Syndr (2016) 0.79
Telmisartan prevents high-fat diet-induced hypertension and decreases perirenal fat in rats. J Biomed Res (2012) 0.79
Elevated blood pressure, heart rate and body temperature in mice lacking the XLαs protein of the Gnas locus is due to increased sympathetic tone. Exp Physiol (2013) 0.79
Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance. Am J Physiol Renal Physiol (2016) 0.79
Association of leptin and insulin with childhood obesity and retinal vessel diameters. Int J Obes (Lond) (2013) 0.79
Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation. Am J Physiol Endocrinol Metab (2014) 0.79
Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study. Hypertens Res (2015) 0.77
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome. Front Neurosci (2016) 0.77
Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viability. J Inorg Biochem (2012) 0.77
The Role of Aldosterone in Obesity-Related Hypertension. Am J Hypertens (2016) 0.77
Clinical predictors of ventilatory threshold achievement in patients with claudication. Med Sci Sports Exerc (2015) 0.77
Leptin regulates CD16 expression on human monocytes in a sex-specific manner. Physiol Rep (2014) 0.77
High-fat food, sympathetic nerve activity, and hypertension: danger soon after the first bite? Hypertension (2012) 0.77
Neural Control of Non-vasomotor Organs in Hypertension. Curr Hypertens Rep (2016) 0.77
Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.76
Sex differences in blood pressure control in SHR: lack of a role for EETs. Physiol Rep (2014) 0.76
High-fat diet-induced hypertension and autonomic imbalance are associated with an upregulation of CART in the dorsomedial hypothalamus of mice. Physiol Rep (2016) 0.76
Lean heart: Role of leptin in cardiac hypertrophy and metabolism. World J Cardiol (2015) 0.76
Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats. Sci Rep (2016) 0.76
Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486. Nutr Diabetes (2016) 0.76
Association of ambulatory heart rate and atherosclerosis risk factors with blood pressure in young non-hypertensive adults. Open Heart (2016) 0.75
Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. Am J Physiol Endocrinol Metab (2016) 0.75
Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension. Physiol Rep (2014) 0.75
The role of leptin in the ventricular remodeling process and its mechanism. Int J Clin Exp Med (2015) 0.75
Effects of leptin on sympathetic nerve activity in conscious mice. Physiol Rep (2015) 0.75
Vascular smooth muscle-specific deletion of the leptin receptor attenuates leptin-induced alterations in vascular relaxation. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice. PLoS One (2015) 0.75
Reduced vagal control of the heart in high-fat diet mice: a potential role of increased butyrylcholinesterase. Physiol Rep (2015) 0.75
Predicting increased blood pressure using machine learning. J Obes (2014) 0.75
Perirenal Fat and Association With Metabolic Risk Factors: The Uberlândia Heart Study. Medicine (Baltimore) (2015) 0.75
Increased circulating ANG II and TNF-α represents important risk factors in obese saudi adults with hypertension irrespective of diabetic status and BMI. PLoS One (2012) 0.75
An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy. Int J Hypertens (2016) 0.75
Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin. Am J Physiol Renal Physiol (2015) 0.75
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans. J Appl Physiol (1985) (2010) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell (2005) 7.04
Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med (2001) 5.90
Genetics of obesity in humans. Endocr Rev (2006) 5.42
Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med (2006) 4.22
Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab (1999) 3.26
Prevalence of obesity among US preschool children in different racial and ethnic groups. Arch Pediatr Adolesc Med (2009) 3.16
Studies on the physiological functions of the melanocortin system. Endocr Rev (2006) 3.11
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00
Molecular and anatomical determinants of central leptin resistance. Nat Neurosci (2005) 2.98
Obesity-associated hypertension: new insights into mechanisms. Hypertension (2004) 2.86
Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med (2008) 2.86
The kidney, hypertension, and obesity. Hypertension (2003) 2.79
Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci U S A (2004) 2.57
Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension (2006) 2.41
The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest (2005) 2.40
Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A (2004) 2.36
Sympathetic neural activation in visceral obesity. Circulation (2002) 2.34
Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab (2009) 2.27
Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension (2008) 1.98
Leptin signaling and obesity: cardiovascular consequences. Circ Res (2007) 1.95
Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension (1999) 1.82
Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension (2006) 1.80
Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (2005) 1.72
Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol (2004) 1.68
Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes (2001) 1.62
Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens (2002) 1.45
Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens (1999) 1.42
Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension (2002) 1.40
Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther (2004) 1.40
Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension (2004) 1.39
Pathophysiology and treatment of obesity hypertension. Curr Pharm Des (2004) 1.37
The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep (2009) 1.29
Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage. Circulation (2009) 0.91
Crossing the border: developmental regulation of leptin transport to the brain. Endocrinology (2008) 0.89
Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension (2008) 1.98
Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension (2006) 1.80
Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (2005) 1.72
Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death. Free Radic Biol Med (2007) 1.56
Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension. Hypertension (2008) 1.51
Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circ Res (2013) 1.42
Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion. Free Radic Biol Med (2007) 1.38
HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol (2006) 1.35
Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension (2011) 1.30
Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension (2004) 1.29
The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep (2009) 1.29
Hypertension: physiology and pathophysiology. Compr Physiol (2012) 1.18
Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens (2003) 1.18
Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension (2003) 1.14
Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension (2011) 1.14
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.13
Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol (2005) 1.13
A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes (2009) 1.10
Renal vascular responses to CORM-A1 in the mouse. Pharmacol Res (2006) 1.08
Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol (2011) 1.06
Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice. Hypertension (2005) 1.05
Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. Am J Physiol Heart Circ Physiol (2008) 1.04
ENaC proteins contribute to VSMC migration. Am J Physiol Heart Circ Physiol (2006) 0.99
Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells. Am J Physiol Renal Physiol (2008) 0.98
Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. Am J Physiol Regul Integr Comp Physiol (2013) 0.97
Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. Am J Physiol Regul Integr Comp Physiol (2013) 0.96
Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.96
Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol (2010) 0.96
Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats. Peptides (2013) 0.94
Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity. J Nutr (2010) 0.93
Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther (2011) 0.92
Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. J Hypertens (2010) 0.91
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.91
Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension (2013) 0.91
Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life (2013) 0.90
Role of leptin and central nervous system melanocortins in obesity hypertension. Curr Opin Nephrol Hypertens (2013) 0.90
Targeting endothelial cells with heme oxygenase-1 gene using VE-cadherin promoter attenuates hyperglycemia-mediated cell injury and apoptosis. Antioxid Redox Signal (2007) 0.90
Cardiovascular, renal, and metabolic responses to chronic central administration of agouti-related peptide. Hypertension (2004) 0.89
Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway. Am J Physiol Renal Physiol (2006) 0.88
Heme oxygenase, a novel target for the treatment of hypertension and obesity? Am J Physiol Regul Integr Comp Physiol (2011) 0.87
ENaC proteins are required for NGF-induced neurite growth. Am J Physiol Cell Physiol (2005) 0.87
Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation. Hypertension (2011) 0.87
Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens (2013) 0.87
Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight. Pflugers Arch (2012) 0.86
Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells. Am J Physiol Regul Integr Comp Physiol (2009) 0.85
The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda) (2014) 0.85
Renal inflammation and elevated blood pressure in a mouse model of reduced {beta}-ENaC. Am J Physiol Renal Physiol (2011) 0.84
Spermicidal bacteriocins: lacticin 3147 and subtilosin A. Bioorg Med Chem Lett (2007) 0.84
Perinatal salt restriction: a new pathway to programming insulin resistance and dyslipidemia in adult wistar rats. Pediatr Res (2004) 0.84
Cold preservation mediated renal injury: involvement of mitochondrial oxidative stress. Ren Fail (2008) 0.84
Chronic effects of centrally administered adiponectin on appetite, metabolism and blood pressure regulation in normotensive and hypertensive rats. Peptides (2012) 0.84
Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney? Curr Pharm Biotechnol (2012) 0.83
Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.82
Chronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet. J Hypertens (2011) 0.82
Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertens Res (2013) 0.82
Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity. Am J Physiol Regul Integr Comp Physiol (2012) 0.81
The treatment of hypertension in obese patients. Curr Hypertens Rep (2008) 0.81
In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor. Pharmacol Res (2010) 0.81
Renal Inhibition of Heme Oxygenase-1 Increases Blood Pressure in Angiotensin II-Dependent Hypertension. Int J Hypertens (2011) 0.81
Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J Neurosurg (2004) 0.80
Fenoldopam preconditioning: role of heme oxygenase-1 in protecting human tubular cells and rodent kidneys against cold-hypoxic injury. Transplantation (2011) 0.80
Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses. Brain Res (2003) 0.79
Polymer loop formation on a functionalized hard surface: quantitative insight by comparison of experimental and Monte Carlo simulation results. Langmuir (2010) 0.78
The Modulatory Role of Heme Oxygenase on Subpressor Angiotensin II-Induced Hypertension and Renal Injury. Int J Hypertens (2012) 0.78
Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake. J Hypertens (2006) 0.77
Sex-specific effects of heme oxygenase-2 deficiency on renovascular hypertension. J Am Soc Hypertens (2013) 0.77
Heme oxygenase-1 promotes migration and β-epithelial Na+ channel expression in cytotrophoblasts and ischemic placentas. Am J Physiol Regul Integr Comp Physiol (2014) 0.77
Maternal high-sodium intake alters the responsiveness of the renin-angiotensin system in adult offspring. Life Sci (2012) 0.76
Splenic reflex modulation of central cardiovascular regulatory pathways. Am J Physiol Regul Integr Comp Physiol (2007) 0.76
Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats. J Hypertens (2015) 0.75
Smart gene therapy for the heart. Hypertension (2004) 0.75